234 related articles for article (PubMed ID: 2744632)
1. The contribution of individual lipoproteins to the degradation of platelet-activating factor in human serum.
Ostermann G; Kostner GM; Gries A; Malle E; Till U
Haemostasis; 1989; 19(3):160-8. PubMed ID: 2744632
[TBL] [Abstract][Full Text] [Related]
2. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.
Stafforini DM; McIntyre TM; Carter ME; Prescott SM
J Biol Chem; 1987 Mar; 262(9):4215-22. PubMed ID: 3549727
[TBL] [Abstract][Full Text] [Related]
3. PAF-acetylhydrolase, predominantly present in LDL in healthy subjects, is associated with HDL in a patient with LDL deficiency.
Surya II; Mommersteeg M; Erkelens DW; Akkerman JW
J Lipid Mediat; 1991; 3(1):27-38. PubMed ID: 1768838
[TBL] [Abstract][Full Text] [Related]
4. The degradation of platelet-activating factor in the plasma of a patient with familial high density lipoprotein deficiency (Tangier disease).
Pritchard PH; Chonn A; Yeung CC
Blood; 1985 Dec; 66(6):1476-8. PubMed ID: 4063532
[TBL] [Abstract][Full Text] [Related]
5. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility.
McCall MR; La Belle M; Forte TM; Krauss RM; Takanami Y; Tribble DL
Biochim Biophys Acta; 1999 Jan; 1437(1):23-36. PubMed ID: 9931415
[TBL] [Abstract][Full Text] [Related]
6. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from healthy habitual cigarette smokers.
Imaizumi T; Satoh K; Yoshida H; Kawamura Y; Hiramoto M; Koyanagi M; Takamatsu S; Takamatsu M
Heart Vessels; 1990; 5(2):81-6. PubMed ID: 2354992
[TBL] [Abstract][Full Text] [Related]
7. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor.
Ambrosio G; Oriente A; Napoli C; Palumbo G; Chiariello P; Marone G; Condorelli M; Chiariello M; Triggiani M
J Clin Invest; 1994 Jun; 93(6):2408-16. PubMed ID: 8200975
[TBL] [Abstract][Full Text] [Related]
8. Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma.
Stafforini DM; Carter ME; Zimmerman GA; McIntyre TM; Prescott SM
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2393-7. PubMed ID: 2928339
[TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor acetylhydrolase in human seminal plasma.
Letendre ED; Miron P; Roberts KD; Langlais J
Fertil Steril; 1992 Jan; 57(1):193-8. PubMed ID: 1730316
[TBL] [Abstract][Full Text] [Related]
10. PAF-acetylhydrolase activity of Lp(a) before and during Cu(2+)-induced oxidative modification in vitro.
Karabina SA; Elisaf MC; Goudevenos J; Siamopoulos KC; Sideris D; Tselepis AD
Atherosclerosis; 1996 Aug; 125(1):121-34. PubMed ID: 8831934
[TBL] [Abstract][Full Text] [Related]
11. PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme.
Tselepis AD; Dentan C; Karabina SA; Chapman MJ; Ninio E
Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1764-73. PubMed ID: 7583554
[TBL] [Abstract][Full Text] [Related]
12. Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases.
Dulioust A; Hilliquin P; Menkes CJ; Benveniste J; Arnoux B
Scand J Rheumatol; 1992; 21(4):161-4. PubMed ID: 1529281
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
Tsoukatos DC; Liapikos TA; Tselepis AD; Chapman MJ; Ninio E
Biochem J; 2001 Jul; 357(Pt 2):457-64. PubMed ID: 11439095
[TBL] [Abstract][Full Text] [Related]
14. Release of platelet-activating factor in systemic lupus erythematosus.
Tetta C; Bussolino F; Modena V; Montrucchio G; Segoloni G; Pescarmona G; Camussi G
Int Arch Allergy Appl Immunol; 1990; 91(3):244-56. PubMed ID: 2354868
[TBL] [Abstract][Full Text] [Related]
15. Altered platelet activating factor metabolism in insulin dependent diabetes mellitus.
Memon RA; Saeed SA; Jabbar A; Jafri A; Gilani AH; Saleem S; Akbani H
J Pak Med Assoc; 1995 May; 45(5):122-5. PubMed ID: 7563575
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein.
Stafforini DM; Tjoelker LW; McCormick SP; Vaitkus D; McIntyre TM; Gray PW; Young SG; Prescott SM
J Biol Chem; 1999 Mar; 274(11):7018-24. PubMed ID: 10066756
[TBL] [Abstract][Full Text] [Related]
17. Human plasma platelet-activating factor acetylhydrolase. Purification and properties.
Stafforini DM; Prescott SM; McIntyre TM
J Biol Chem; 1987 Mar; 262(9):4223-30. PubMed ID: 3558407
[TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor acetylhydrolase activity in bovine seminal plasma.
Parks JE; Hough SR
J Androl; 1993; 14(5):335-9. PubMed ID: 8288488
[TBL] [Abstract][Full Text] [Related]
19. High-density lipoprotein inhibits the production of platelet activating factor acetylhydrolase by HepG2 cells.
Satoh K; Imaizumi T; Yoshida H; Takamatsu S
J Lab Clin Med; 1994 Feb; 123(2):225-31. PubMed ID: 8301198
[TBL] [Abstract][Full Text] [Related]
20. Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL.
Tsoukatos DC; Arborati M; Liapikos T; Clay KL; Murphy RC; Chapman MJ; Ninio E
Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3505-12. PubMed ID: 9437199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
